The ratings of three Health Care Provider stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
This week, Mednax Inc. (NYSE:MD) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Mednax provides physician management services to hospital-based neonatal, maternal-fetal, pediatric cardiology, and pediatric intensive care specialties. As of August 7, 10.2% of outstanding Mednax Inc. shares were held short. For a full analysis of MD stock, visit Portfolio Grader.
Tenet Healthcare (NYSE:THC) experiences a ratings drop this week, going from last week’s C to a D. Tenet Healthcare is an investor-owned health care services company that mainly operates general hospitals and related health care facilities. The stock also rates an F in Margin Growth. The stock currently has a trailing PE Ratio of 42.4. To get an in-depth look at THC, get Portfolio Grader’s complete analysis of THC stock.
This week, China Cord Blood‘s (NYSE:CO) rating worsens to a D from the company’s C rating a week ago. China Cord Blood engages in the provision of umbilical cord blood storage and ancillary services in its cord blood banks. The stock also gets an F in Earnings Revisions. For more information, get Portfolio Grader’s complete analysis of CO stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.